Relates the gripping story of a major public health effort diverted and distorted for private gain.

This book is both a powerful personal memoir and the definitive history of an organization that helped change American society. Jack Greenberg was a key figure at the NAACP Legal Defense and Educational Fund (LDF) for some thirty-five years. Most of the cases we associate from that period--school integration, equal employment, fair housing, voter registration--were LDF cases, either argued by Greenberg himself or litigated under his direction. Greenberg represented Martin Luther King, Jr., in Birmingham and won for him the right to march from Selma to Montgomery. Under Greenberg's leadership, the LDF forced the University of Mississippi to admit James Meredith and integrated the University of Alabama when George Wallace stood in the schoolhouse door. Greenberg won the cases in which the Supreme Court repudiated the "all deliberate speed" doctrine, which had made school desegregation intolerably slow. Through the 1970s and 1980s, LDF tackled most of the important cases that enforced the new civil rights legislation of the 1960s involving public accommodations, employment, education, and health care, and started the campaigns for prisoners' rights and against capital punishment. More than a history of the litigation that made the LDF so important, the book offers unique insights into its strategies, courtroom techniques, values, and personal relationships. Filled with stories only Greenberg could tell of his experiences with Thurgood Marshall, Martin Luther King, Jr., Marian Wright Edelman, Lani Guinier, Roy Wilkins, Vernon Jordan, Charlayne Hunter-Gault, Lyndon Johnson, and scores of others, Crusaders in the Courts is an epic saga of a critical period in American history as well as the poignant personal story of the evolution of a white Jewish lawyer into a major civil rights advocate.

In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges are compounded by the pressures of globalization, the introduction of novel technologies, and fast-evolving threats to public health. With essays by leading scholars and government and private-industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good. The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off-label drug marketing and the proper role of the FDA before and after a drug goes on the market. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad.

"Written for a broad audience, this book looks at Supreme Court decisions, legal history, and public health theory to tell the story of how the Supreme Court stymied efforts to control the pandemic, as well as how its pre-pandemic decisions left the United States especially vulnerable to COVID-19 and other health threats"--

"Written for a broad audience, this book looks at Supreme Court decisions, legal history, and public health theory to tell the story of how the Supreme Court stymied efforts to control the pandemic, as well as how its pre-pandemic decisions left the United States especially vulnerable to COVID-19 and other health threats"--

A fundamental tension in the American political and legal landscape is this: individual liberty v. the common good. When does one trump the other? This ongoing tension becomes particularly problematic when new threats to public health appear, such as HIV or pandemic influenza. Parmet explores this terrain by offering a population-based approach to legal analysis, claiming that law should seek, among other things, to protect and promote public health--something that has been badly neglected, she claims, in legal discourse and biomedical models of disease in our hyper-individualistic society. In the first few chapters she defines public health, establishing its importance to human activity, and lays out the basics of a population-based approach. In subsequent chapters she employs this approach to several issues: constitutional law, health law, tort law, international law and human rights, as well as specific controversial subjects such as obesity--to what degree should law govern the fast food industry?--the use of tobacco, toxic chemicals, global warming, and the emergence of new infections. Along the way she demonstrates how a population-based approach can better help us analyze, for example, the relationship between health and socioeconomic status. The book concludes with Parmet's musings on the future of population-based legal analysis and its central claim: that by recognizing the importance of public health law, and also recognizing the interests of the individual, we can not only better protect the health of communities but also enhance contemporary legal discourse.